Injections should not be given by routes other than those recommended. Not to be administered intraperitoneally.

Trimacare 24% is contra-indicated in animals with known sulphonamide sensitivity, severe liver parenchymal damage, or blood dyscrasias.

Milk for human consumption must not be taken from a cow during treatment. Milk for human consumption may only be take after 48 hours from the last treatment.

Animals must not be slaughtered for human consumption during treatment. Cattle may be slaughtered for human consumption only after 12 days from the last treatment. Pigs may be slaughtered for human consumption only after 20 days from the last treatment.

Adequate drinking water should be available during the therapeutic effect of the product.

Not to be used in horses intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.

Do not administer to horses exhibiting drug-induced cardiac arrhythmias. Such arrhythmias may be associated with the administration of certain anaesthetic and sedative agents.

Potentially fatal anaphlylactic shock has been observed on rare occasions following administration of potentiated sulphonamide preparations, particularly by the intravenous route. Veterinary surgeons should be mindful of this possibility during the injection process. For intravenous administration the product should be warmed to body temperature and injected slowly over as long a period as is reasonably practical. At the first sign of intolerance the injection should be interrupted and shock treatment initiated.

Care must be taken to avoid accidental self-injection.